1716 related articles for article (PubMed ID: 15793561)
1. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
James C; Ugo V; Le Couédic JP; Staerk J; Delhommeau F; Lacout C; Garçon L; Raslova H; Berger R; Bennaceur-Griscelli A; Villeval JL; Constantinescu SN; Casadevall N; Vainchenker W
Nature; 2005 Apr; 434(7037):1144-8. PubMed ID: 15793561
[TBL] [Abstract][Full Text] [Related]
2. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Scott LM; Tong W; Levine RL; Scott MA; Beer PA; Stratton MR; Futreal PA; Erber WN; McMullin MF; Harrison CN; Warren AJ; Gilliland DG; Lodish HF; Green AR
N Engl J Med; 2007 Feb; 356(5):459-68. PubMed ID: 17267906
[TBL] [Abstract][Full Text] [Related]
3. Identification of an acquired JAK2 mutation in polycythemia vera.
Zhao R; Xing S; Li Z; Fu X; Li Q; Krantz SB; Zhao ZJ
J Biol Chem; 2005 Jun; 280(24):22788-92. PubMed ID: 15863514
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mechanisms in myeloproliferative disorders.
Delhommeau F; Pisani DF; James C; Casadevall N; Constantinescu S; Vainchenker W
Cell Mol Life Sci; 2006 Dec; 63(24):2939-53. PubMed ID: 17131059
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.
Pearson S; Williamson AJK; Blance R; Somervaille TCP; Taylor S; Azadbakht N; Whetton AD; Pierce A
Leukemia; 2017 Dec; 31(12):2717-2725. PubMed ID: 28533538
[TBL] [Abstract][Full Text] [Related]
6. Isolated cerebellar infarction in a case of JAK 2 mutation-negative polycythemia vera: A case report.
Krishnan P
Brain Circ; 2022; 8(4):225-227. PubMed ID: 37181843
[TBL] [Abstract][Full Text] [Related]
7. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.
McMullin MFF; Mead AJ; Ali S; Cargo C; Chen F; Ewing J; Garg M; Godfrey A; Knapper S; McLornan DP; Nangalia J; Sekhar M; Wadelin F; Harrison CN;
Br J Haematol; 2019 Jan; 184(2):161-175. PubMed ID: 30426472
[No Abstract] [Full Text] [Related]
8. Erythro-leukæmia (Polycythæmia Rubra Vera-Vaquez's Disease-Associated with Myeloid Leukæmia).
Stolkind E
Proc R Soc Med; 1933 Nov; 27(1):19-22. PubMed ID: 19989541
[No Abstract] [Full Text] [Related]
9. Erythro-leukæmia (Leukæmia following Long-standing Erythræmia-Polycythæmia Vera, Vaquez's Disease).
Stolkind E
Proc R Soc Med; 1935 Jan; 28(3):339-40. PubMed ID: 19990118
[No Abstract] [Full Text] [Related]
10. Polycythæmia Vera with Nervous and Ocular Disorders.
Stolkind E
Proc R Soc Med; 1931 May; 24(7):925. PubMed ID: 19988139
[No Abstract] [Full Text] [Related]
11. A Case of Polycythæmia Vera in which Phenyl hydrazine Treatment was followed by Acute Platelet Reactions.
Hare DC
Proc R Soc Med; 1936 Aug; 29(10):1222-3. PubMed ID: 19990809
[No Abstract] [Full Text] [Related]
12. Polycythæmia Vera.
Hunt TC
Proc R Soc Med; 1933 Feb; 26(4):364. PubMed ID: 19989124
[No Abstract] [Full Text] [Related]
13. Polycythæmia Vera, with Cerebral Thrombosis.
Stolkind E
Proc R Soc Med; 1931 May; 24(7):923-5. PubMed ID: 19988136
[No Abstract] [Full Text] [Related]
14. Polycythæmia Vera Treated with Phenylhydrazine.
East T
Proc R Soc Med; 1930 Feb; 23(4):428-9. PubMed ID: 19987362
[No Abstract] [Full Text] [Related]
15. Chronic Hæmolytic Polycythæmia.
Rau L; Pulvertaft RJ; Humble JG
Proc R Soc Med; 1946 Apr; 39(6):307-8. PubMed ID: 19993282
[No Abstract] [Full Text] [Related]
16. Polycythæmia.
Thompson T
Proc R Soc Med; 1909; 2(Clin Sect):25-6. PubMed ID: 19973423
[No Abstract] [Full Text] [Related]
17. Polycythæmia.
Miller CH
Proc R Soc Med; 1909; 2(Clin Sect):24-5. PubMed ID: 19973420
[No Abstract] [Full Text] [Related]
18. A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R; Passamonti F; Buser AS; Teo SS; Tiedt R; Passweg JR; Tichelli A; Cazzola M; Skoda RC
N Engl J Med; 2005 Apr; 352(17):1779-90. PubMed ID: 15858187
[TBL] [Abstract][Full Text] [Related]
19. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Levine RL; Wadleigh M; Cools J; Ebert BL; Wernig G; Huntly BJ; Boggon TJ; Wlodarska I; Clark JJ; Moore S; Adelsperger J; Koo S; Lee JC; Gabriel S; Mercher T; D'Andrea A; Fröhling S; Döhner K; Marynen P; Vandenberghe P; Mesa RA; Tefferi A; Griffin JD; Eck MJ; Sellers WR; Meyerson M; Golub TR; Lee SJ; Gilliland DG
Cancer Cell; 2005 Apr; 7(4):387-97. PubMed ID: 15837627
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
